Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-18

Clinical Trial Update: Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer Patients

View source ↗

Summary

A clinical trial is investigating blood-based biomarkers to predict the response to therapy in prostate cancer patients and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Oncology Institute of Southern Switzerland | Conditions: Prostate Cancer | Status: RECRUITING